ATROLAK

This brand name is authorized in Spain, Poland, United Kingdom

Active ingredients

The drug ATROLAK contains one active pharmaceutical ingredient (API):

1 Quetiapine
UNII 2S3PL1B6UJ - QUETIAPINE FUMARATE

Quetiapine is an atypical antipsychotic agent. Quetiapine and the active human plasma metabolite, norquetiapine interact with a broad range of neurotransmitter receptors.

Read about Quetiapine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ATROLAK Prolonged-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AH04 Quetiapine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 74755, 74757, 74758, 77977, 81048
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 278423, 278425, 278427, 278429, 349369
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100261341, 100261358, 100261364, 100303884, 100373301

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.